The use of statistics to support discovery and testing of new medicines has grown exponentially since the 1962 Kefauver-Harris Amendments. These amendments required drug sponsors to prove a product’s safety and efficacy in controlled clinical trials in order to take a product to market. The statistician’s role “to assist the process of developing medicines which… Read more »